 |
|
|
 |
|
Drug Combo Fights Recurrent Ovarian Cancer Cell Growth
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 The drug is a synthetic version of a compound isolated from the sea squirt, a tubular marine creature used in numerous medical studies. The drug binds to the DNA of cancer cells and blocks their ability to multiply, according to information in the UC Irvine news release.
Each year in the United States, about 20,000 women are diagnosed with ovarian cancer, and about 15,000 die of the disease. When the disease is detected early (confined to the ovaries), about 90 percent of patients live at least five years. But when ovarian cancer is detected after it's spread, only about 30 percent of patients survive five years.
More information
Text Continues Below

The American Cancer Society has more about ovarian cancer.
Page: << Prev | 1 | 2
-- Robert Preidt
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 9/18/2008
|
 |

SPURCE: University of California, Irvine, news release, Sept. 15, 2008
|